Mike Polark
Stock Analyst at Wolfe Research
(3.02)
# 1,298
Out of 5,126 analysts
84
Total ratings
44.64%
Success rate
1.74%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDLN Medline | Initiates: Outperform | $47 | $47.30 | -0.63% | 1 | Jan 12, 2026 | |
| IRTC iRhythm Holdings | Maintains: Outperform | $235 → $220 | $146.47 | +50.20% | 13 | Dec 16, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $125 → $180 | $65.70 | +173.97% | 9 | Dec 4, 2025 | |
| EW Edwards Lifesciences | Upgrades: Peer Perform | n/a | $78.71 | - | 5 | Oct 29, 2025 | |
| MDT Medtronic | Upgrades: Peer Perform | n/a | $102.90 | - | 3 | Jun 30, 2025 | |
| BBNX Beta Bionics | Initiates: Outperform | $20 | $13.08 | +52.91% | 1 | May 30, 2025 | |
| LIVN LivaNova | Upgrades: Outperform | $60 | $66.56 | -9.86% | 9 | May 20, 2025 | |
| PODD Insulet | Upgrades: Outperform | $350 | $241.93 | +44.67% | 4 | May 13, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Outperform | $29 | $25.51 | +13.68% | 1 | Mar 31, 2025 | |
| RMD ResMed | Downgrades: Underperform | $180 | $271.63 | -33.73% | 5 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $89.91 | - | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $405 | $358.29 | +13.04% | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $487 → $503 | $488.15 | +3.04% | 7 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $110.83 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $108.42 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $69.97 | +72.93% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $19.17 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $17.75 | +40.85% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $139.15 | +18.58% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $76.27 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $15.67 | -17.04% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $4.65 | +351.61% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $252.16 | -0.86% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $1.43 | +2,906.99% | 1 | Sep 2, 2020 |
Medline
Jan 12, 2026
Initiates: Outperform
Price Target: $47
Current: $47.30
Upside: -0.63%
iRhythm Holdings
Dec 16, 2025
Maintains: Outperform
Price Target: $235 → $220
Current: $146.47
Upside: +50.20%
Inspire Medical Systems
Dec 4, 2025
Maintains: Outperform
Price Target: $125 → $180
Current: $65.70
Upside: +173.97%
Edwards Lifesciences
Oct 29, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $78.71
Upside: -
Medtronic
Jun 30, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $102.90
Upside: -
Beta Bionics
May 30, 2025
Initiates: Outperform
Price Target: $20
Current: $13.08
Upside: +52.91%
LivaNova
May 20, 2025
Upgrades: Outperform
Price Target: $60
Current: $66.56
Upside: -9.86%
Insulet
May 13, 2025
Upgrades: Outperform
Price Target: $350
Current: $241.93
Upside: +44.67%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Outperform
Price Target: $29
Current: $25.51
Upside: +13.68%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $271.63
Upside: -33.73%
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $89.91
Upside: -
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $358.29
Upside: +13.04%
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $488.15
Upside: +3.04%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $110.83
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $108.42
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $69.97
Upside: +72.93%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $19.17
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $17.75
Upside: +40.85%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $139.15
Upside: +18.58%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $76.27
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $15.67
Upside: -17.04%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $4.65
Upside: +351.61%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $252.16
Upside: -0.86%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $1.43
Upside: +2,906.99%